Celerion

Overview

Celerion is a global contract research organization (CRO) headquartered in Lincoln, Nebraska, specializing in early-phase clinical research and bioanalytical sciences. With over 50 years of experience conducting 6,000+ studies, Celerion operates the largest global network of early-phase clinical research facilities in the industry.

Clinical Services

Celerion provides comprehensive early-phase clinical research services across all stages of drug development, from preclinical through late-stage clinical. The organization operates 650+ beds worldwide across facilities in North America, Europe, and Asia, conducting trials in 30 countries. Services include:

• Early-phase clinical pharmacology studies
• Global clinical development support
• Data management and biometrics
• Drug development and regulatory affairs consultation

Bioanalytical Sciences

Celerion's bioanalytical laboratories in Lincoln, Nebraska and Zurich, Switzerland provide end-to-end bioanalytical support for drug developers. The labs are equipped with latest technologies for:

• Pharmacokinetic (PK) analysis
• Immunogenicity assays
• Biomarker assays
• Analysis of small and large molecules across all development phases

Differentiation

Celerion emphasizes speed, experience, global reach, and innovation. The organization optimizes studies for efficiency at every stage to generate actionable data faster than competitors, leveraging advanced facilities and data acquisition strategies.